While the struggle for cannabis reform goes on in the United Kingdom, GW Pharmaceuticals is laughing all the way to the bank. At the beginning of the month, NICE (the friendly-sounding drugs advisory body) issued stringent and narrow guidelines for prescriptions of cannabinoid medication that sounded...